Free tool
FAERS Monitor: Doral
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018708 or its brand name (Doral, Quazepam). Reports on generic versions are filed under their own applications.
Reports
302
Serious
274
91% of reports
Hospitalization
136
Death reported
47
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- suicide attempt27
- altered state of consciousness26
- intentional overdose25
- hypoglycaemia18
- completed suicide17
- pyrexia16
- overdose15
- somnolence15
- delirium13
- fall13
- nausea13
- blood creatine phosphokinase increased12
- inappropriate antidiuretic hormone secretion12
- toxicity to various agents12
- insomnia11
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 7 |
| 2006 | 11 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 18 |
| 2012 | 14 |
| 2013 | 15 |
| 2014 | 15 |
| 2015 | 41 |
| 2016 | 22 |
| 2017 | 29 |
| 2018 | 37 |
| 2019 | 10 |
| 2020 | 8 |
| 2021 | 10 |
| 2022 | 13 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,857 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| altered state of consciousnessSignal | 26 | 83.7 | 57.9 | 2,042 |
| inappropriate antidiuretic hormone secretionSignal | 12 | 81.5 | 46.8 | 874 |
| suicide attemptSignal | 27 | 31.0 | 21.6 | 757 |
| blood creatine phosphokinase increasedSignal | 12 | 29.0 | 16.7 | 298 |
| intentional overdoseSignal | 25 | 27.2 | 18.7 | 606 |
| deliriumSignal | 13 | 26.1 | 15.3 | 290 |
| hypoglycaemiaSignal | 18 | 25.9 | 16.5 | 406 |
| completed suicideSignal | 17 | 14.2 | 9.0 | 197 |
| somnolenceSignal | 15 | 5.2 | 3.2 | 47 |
| toxicity to various agentsSignal | 12 | 5.0 | 2.8 | 34 |
| overdoseSignal | 15 | 4.8 | 3.0 | 42 |
| pyrexiaSignal | 16 | 3.2 | 2.0 | 23 |
| insomniaSignal | 11 | 2.9 | 1.6 | 12 |
| fallSignal | 13 | 2.7 | 1.6 | 13 |
| nausea | 13 | 1.1 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.